Alexandria Real Estate Equities, Inc. (ARE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile by GlobalData

VIEWS: 0 PAGES: 53

Alexandria Real Estate Equities, Inc. is a real estate investment trust, which carries out the development and management of science-driven cluster formation. The principal activities of the company comprise real estate, technical infrastructure and services to the life science industry. The company's clients include universities, independent not-for-profit institutions, pharmaceutical, biopharmaceutical, medical device, product, service, and translational entities, and government agencies. The company has over 173 properties located in the United States and Canada. that contain over 15.6 million square feet rentable space. The company is headquartered in Pasadena, California, the US.

More Info
									        Alexandria Real Estate Equities, Inc. (ARE) - Pharmaceuticals & Healthcare -
                                Deals and Alliances Profile
       Reference Code: GDPH27169D                                                                                                               Publication Date: JAN 2013

      Company Overview                                                                                         Key Facts
      Alexandria Real Estate Equities, Inc. is a real estate investment trust, which carries
                                                                                                               Alexandria Real Estate Equities, Inc.,
      out the development and management of science-driven cluster formation. The
                                                                                                               Pharmaceuticals & Healthcare, Key Facts, 2011
      principal activities of the company comprise real estate, technical infrastructure and
      services to the life science industry. The company's clients include universities,                        Web Address                        www.are.com
      independent not-for-profit institutions, pharmaceutical, biopharmaceutical, medical
                                                                                                                Revenue (US$ million)                                     573.44
      device, product, service, and translational entities, and government agencies. The
      company has over 173 properties located in the United States and Canada. that                             Number of Employees                                         212
      contain over 15.6 million square feet rentable space. The company is headquartered                        GlobalData
      in Pasadena, California, the US.

      Financial Deals Landscape
        Alexandria Real Estate Equities, Inc., Pharmaceuticals &                          Alexandria Real Estate Equities, Inc., Pharmaceuticals &
        Healthcare, Deals by Type, 2007 to YTD 2013                                       Healthcare, Deals By Year, 2007 to YTD 2013

                                                                                                          6
                                                                                                                                    5
                                                                                                          5
                                                                                                                             4

                                                                                           No. of Deals
                                                                                                          4
                                                                                                                  3                        3
                                                                                                          3
                                                                                                          2
                                                                                                                                                   1        1
                                                                                                          1
                                                                                                                                                                      0
                                                                                                          0
                                                                                                                2007        2008   2009   2010    2011     2012   YTD
                                                                                                                                                                  2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from        from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Alexandria Real Estate Equities, Inc., Pharmaceuticals &                         Alexandria Real Estate Equities, Inc., Pharmaceuticals &
         Healthcare, Deals By Region, 2007 to YTD 2013                                    Healthcare, Deals By Therapy Area, 2007 to YTD 2013

                         25                                                                               14           12
          No. of Deals




                                                                                                          12                       10
                                                                                           No. of Deals




                         20     23
                                                                                                          10                                8
                         15
                                                                                                           8
                         10                                                                                6                                           5
                                                                                                                                                                  4
                         5               0         0        0        0                                     4
                         0                                                                                 2
                              North     Asia-    Europe   Middle   South                                   0
                              Americ   Pacific             East     and                                           Infectio Oncolo         Immun Metabo Central
                                a                          and     Central                                           us      gy            ology   lic  Nervou
                                                          Africa   Americ                                          Diseas                        Disord    s
                                                                     a                                               e                             ers  System



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




Alexandria Real Estate Equities, Inc. - Pharmaceuticals &                                                                                         Reference Code: GDPH27169D
Healthcare - Deals and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                         Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Alexandria Real Estate Equities, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ........................................ 3
       Alexandria Real Estate Equities, Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ........................................ 5
       Alexandria Real Estate Equities, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 .................................... 6
       Alexandria Real Estate Equities, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013.......................... 7
       Alexandria Real Estate Equities, Inc., Medical Devices Deals, 2007 to YTD 2013 ............................................................................ 8
       Alexandria Real Estate Equities, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ..................................... 9
       Alexandria Real Estate Equities, Inc., Pharmaceuticals & Healthcare, Deal Details ........................................................................ 13
          Venture Financing......................................................................................................................................................................... 13
             Theraclone Sciences Secures Additional $1 Million In Extended Series B Financing ............................................................... 13
             Acylin Therapeutics Secures $4.4 Million In Series A Venture Financing ................................................................................. 15
             Mirina Raises $3.9 Million In Series A-1 Venture Financing Round .......................................................................................... 17
             Theraclone Sciences Secures An Additional $1.5 Million In Series B Venture Financing ......................................................... 19
             Cerulean Pharma Raises $20 Million In Venture Financing Round........................................................................................... 21
             XORI Secures $2.1 Million In Series A Financing Round .......................................................................................................... 23
             Genocea Biosciences Secures $23 Million In Series A Financing ............................................................................................ 25
             Vivaldi Biosciences Secures $19 Million in Series A Financing................................................................................................. 27
             PharmSelex Secures Series A Financing.................................................................................................................................. 29
             MacroGenics Secures $25 Million In Series D-2 Financing....................................................................................................... 31
             Recodagen Raises Series A Financing ..................................................................................................................................... 34
             Cerulean Pharma Secures $8.1 Million In Series B Financing .................................................................................................. 36
             Allozyne Secures $30 Million In Series B Financing ................................................................................................................. 38
             BioRelix Secures $25.75 Million In Series A Financing ............................................................................................................. 40
          Acquisition .................................................................................
								
To top